Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 153 for “"Myotonic dystrophy"”.
-
Genetic studies in myotonic dystrophy
Promotores : H.H. Ropers en B. Wieringa
-
Lead compound discovery for myotonic dystrophy
Myotonic dystrophy is a debilitating genetic disorder which currently does not have a therapeutic treatment. It is understood that CTG expansions lead to formation of stable poly(CUG) mRNA which mislocalize splicing factors such as MBNL1 and lead to missplicing in the cell. One therapeutic strategy …
-
The molecular basis of myotonic dystrophy
Contains fulltext : mmubn000001_198045182.pdf (Publisher’s version ) (Open Access)
-
Targeting Myotonic Dystrophy with Small Molecules
Myotonic dystrophy (DM) is one of the most common forms of muscular dystrophy, characterized by its hallmark symptom myotonia. DM is an autosomal dominant disease caused by a toxic gain of function RNA. The toxic RNA is produced from expanded non-coding CTG/CCTG repeats, and these CUG/CCUG repeats …
-
Myotonic dystrophy: A study of the expression of the myotonic dystrophy gene in affected tissues and cells.
Recently, the molecular basis of myotonic dystrophy(DM) has been characterized as an unstable trinucleotide CTG repeat amplification in the 3' untranslated region of a gene encoding a protien with serine/threonine kinase activity. As a first step towards understanding the molecular mechanisms …
-
A molecular genetic approach to myotonic dystrophy
Contains fulltext : mmubn000001_132009447.pdf (Publisher’s version ) (Open Access)
-
Understanding Somatic Mosaicism in Myotonic Dystrophy Type 1
Myotonic dystrophy type 1 is caused by an unstable CTG repeat expansion in the 3' UTR of the DM1 protein kinase gene on chromosome 19. A neuromuscular disease with a broad spectrum of symptoms, DM1 also exhibits anticipation whereby disease severity increases through successive generations. …
-
Understanding the pathogenesis of myotonic dystrophy type 1
… we sought to mimic the pathogenesis of myotonic dystrophy type 1 with temporal and spatial control: temporal to reproduce the developmental pathogenesis of the congenital form, and spatial to isolate tissue specific pathology. To do this, we attempted to use the Cre-lox system for the …
-
SATELLITE CELLS AND MYOTONIC DYSTROPHY TYPE 1 (DM1)
Myotonic dystrophy type 1 (DM1) is an autosomal dominant and progressive neuromuscular disorder caused by the CTG trinucleotide repeat expansion in the 3’ untranslated region of the DMPK gene. Clinical manifestations include extensive atrophy of skeletal muscle (SkM) concomitant with muscle …
-
MOLECULAR BASIS OF SKELETAL MUSCLE ATROPHY IN MYOTONIC DYSTROPHY
Myotonic dystrophy (DM) is an autosomal dominant multisystemic disorder characterized by a variety of multisystemic features including myotonia, muscular dystrophy, cardiac dysfunctions, cataracts and insulin-resistance. DM1 is caused by an expanded (CTG)n in the 3’ UTR of the DMPK gene, while DM2 …
-
Towards population-based screening and diagnosis in myotonic dystrophy
No abstract available.
-
Genetic and symptomatic variations in Myotonic Dystrophy Type 1
Myotonic dystrophy type 1 (DM1) is an extremely variable genetic disorder showing an autosomal dominant inheritance that is characterised by myotonia, insulin resistance, cardiac conduction defects and cataracts. It is caused by a trinucleotide repeat expansion of CTG sequence located in the …
-
Analysis of the unstable mutation responsible for myotonic dystrophy.
Myotonic dystrophy (DM) is an autosomal dominant genetic disease which affects approximately 1 in 8000 individuals globally. This is a multisystemic disorder which primarily targets muscle tissues. The genetic defect underlying DM is a highly unstable trinucleotide CTG repeat sequence located in …
-
The brain in myotonic dystrophy type 1: Hammer & Anvil
Contains fulltext : 296449.pdf (Publisher’s version ) (Open Access)
-
Development of therapeutic agents for myotonic dystrophy type 1
Myotonic dystrophy type 1 (DM1) is a multisystemic neuromuscular disorder which is caused by a dominantly inherited (CTG·CAG) repeat expansion in the 3’-UTR of the Dystrophia Myotonica Protein Kinase (DMPK) gene on chromosome 19. The genetic basis of DM1 is that DMPK is transcribed into an mRNA …
-
The regulation of alternative splicing associated with Myotonic Dystrophy
Myotonic Dystrophy (DM) is a genetic disorder with multisystemic symptoms that is caused by expression (as RNA) of expanded repeats of CTG or CCTG in the genome. It is hypothesized that the protein MBNL1 (M[barbelow]uscleb[barbelow]lin[barbelow]d-l[barbelow]ike-1) is sequestered to the expanded CUG …
-
Myotonic Dystrophy: The Structure of CUG Repeats in Solution
Myotonic dystrophy (DM), a genetic and neuromuscular disorder, is the most common form of adult-onset muscular dystrophy resulting in symptoms such as proximal muscle weakness, myotonia, iridescent cataracts and cardiac arrhythmia. Myotonic dystrophy type 1 (DM1), the most prevalent type of DM, is …
-
Employment Status and Work Performance in Adults With Myotonic Dystrophy
… influencing work performance in adults with myotonic dystrophy. The secondary aim was to determine time loss from work due to their health. Study Design This cross-sectional study drew upon data collected from a broader study exploring the prevalence and outcomes of genetic muscle disorders …
-
DNA/RNA-targeted therapeutic approaches for myotonic dystrophy type 1
The student, JuYeon Lee, accepted the attached license on 2018-04-18 at 14:13.
Page 1 of 8